Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3Phase 1 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 46Unknown 17Terminated 9Recruiting 9Not yet recruiting 3Active not recruiting 3Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Stomach Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Pneumonia 1Neoplasms 1Lung Diseases, Interstitial 1Infertility 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1Adenocarcinoma Of Esophagus 1

Interventions

icotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Suspended × Carcinoma, Non-Small-Cell Lung × Clear all
NCT01720901 2015-05-22

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Betta Pharmaceuticals Co., Ltd.

Phase 4 Suspended
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡